๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Randomized phase II study of three doses of oral TAS-108 in postmenopausal patients with metastatic breast cancer

โœ Scribed by Hideo Inaji; Hiroji Iwata; Takahiro Nakayama; Naohito Yamamoto; Yasuyuki Sato; Yutaka Tokuda; Kenjiro Aogi; Shigehira Saji; Kenichi Watanabe; Tsuyoshi Saito; Masayuki Yoshida; Nobuaki Sato; Toshiaki Saeki; Yuichi Takatsuka; Masaru Kuranami; Hiroko Yamashita; Atsushi Kikuchi; Toshio Tabei; Tadashi Ikeda; Shinzaburo Noguchi


Book ID
114703325
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
146 KB
Volume
103
Category
Article
ISSN
1347-9032

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Phase II study of ionidamine in patients
โœ H. Ian Robins; Donna S. Neuberg; Al B. Benson; Kishan J. Pandya; Douglass C. Tor ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› Springer US ๐ŸŒ English โš– 193 KB

The Eastern Cooperative Oncology Group conducted a phase II study of lonidamine in patients with metastatic breast cancer. The drug was given orally to a maximum daily dose of 340 mg/m 2. Forty-two patients were entered on study. One partial response was observed; there were no life-threatening toxi